SRR613114
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Male
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR655590 | GTEX | — | 0.971 |
| 2 | SRR661433 | GTEX | — | 0.957 |
| 3 | SRR602131 | GTEX | — | 0.945 |
| 4 | SRR1329835 | GTEX | — | 0.939 |
| 5 | SRR1488285 | GTEX | — | 0.937 |
| 6 | SRR608598 | GTEX | — | 0.936 |
| 7 | SRR1358561 | GTEX | — | 0.934 |
| 8 | SRR615515 | GTEX | — | 0.933 |
| 9 | SRR1077405 | GTEX | — | 0.932 |
| 10 | SRR1335064 | GTEX | — | 0.927 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 21 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| MYOGENESIS | 0.391 | Inavolisib | — uncovered |
| ANGIOGENESIS | 0.377 | Remibrutinib | — uncovered |
| INFLAMMATORY_RESPONSE | 0.358 | Idelalisib | — uncovered |
| ALLOGRAFT_REJECTION | 0.336 | Idelalisib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.314 | Inavolisib | — uncovered |
| COAGULATION | 0.304 | Binimetinib | — uncovered |
| KRAS_SIGNALING_DN | 0.299 | Remibrutinib | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.294 | Inavolisib | — uncovered |
| KRAS_SIGNALING_UP | 0.257 | Inavolisib | — uncovered |
| TNFA_SIGNALING_VIA_NFKB | 0.213 | Inavolisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.207 | Idelalisib | — uncovered |
| IL2_STAT5_SIGNALING | 0.206 | Idelalisib | — uncovered |
| COMPLEMENT | 0.175 | Inavolisib | — uncovered |
| APICAL_JUNCTION | 0.165 | Inavolisib | — uncovered |
| INTERFERON_ALPHA_RESPONSE | 0.164 | Inavolisib | — uncovered |
| PANCREAS_BETA_CELLS | 0.115 | Cobimetinib | — uncovered |
| ESTROGEN_RESPONSE_LATE | 0.094 | Idelalisib | — uncovered |
| SPERMATOGENESIS | 0.061 | Inavolisib | — uncovered |
| ESTROGEN_RESPONSE_EARLY | 0.058 | Inavolisib | — uncovered |
| BILE_ACID_METABOLISM | 0.052 | Inavolisib | — uncovered |